The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.
mRNA Vaccines: Revolutionizing Disease Prevention
Messenger RNA (mRNA) vaccines have gained prominence,
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Validose Raises $2M to Combat Clinical Trial Non-Adherence with AI-Powered Medication Delivery
What You Should Know:
- Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced today the successful close of a $2 million pre-seed funding round.
- The round was led by Peter Bauer’s Family Office as part of its Technology for Humanity strategy, 10XBeta, and Interstate Fusion Ventures; several angel investors participated.
Validose Revolutionizes Medication Adherence and Precision Dosing
Validose, a healthcare technology company and
Read More
Advancing Drug Development and Regulatory Compliance with AI-Enhanced Real-World Evidence
In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical research and regulatory decisions, recognizing its potential to enhance drug development and improve patient outcomes. This shift includes a focus on sourcing RWD that adheres to strict regulatory standards for effective use in drug approvals and postmarket surveillance.
Unlike traditional
Read More
Medidata Integrates UK Costing Data into Grants Manager, Streamlining Clinical Trial Budgeting
What You Should Know:
- Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions, today announced the integration of data from the UK interactive Costing Tool (iCT) into its Grants Manager platform.
- The collaboration with the National Institute for Health and Care Research (NIHR) provides life sciences organizations with a streamlined and standardized approach to clinical trial budgeting, enhancing efficiency and transparency in research
Read More
Flatiron Health and Exact Sciences Partner to Accelerate Clinical Evidence Generation for MRD Testing in Oncology
What You Should Know:
- Flatiron Health, a leading technology company focused on improving cancer care announced a strategic partnership with Exact Sciences, a pioneer in cancer screening and diagnostics to accelerate clinical evidence generation for Exact Sciences' molecular residual disease (MRD) test, Oncodetect™.
- The collaboration will leverage Flatiron's innovative clinical research platform and extensive network of community oncology practices to study the test's performance
Read More
Helix Launches Largest Clinico-Genomic Data Cohort to Optimize GLP-1’s
What You Should Know:
- Helix, a leader in population genomics and precision health, today announced the launch of a new clinico-genomic dataset comprising over 15,000 patients treated with glucagon-like peptide-1 (GLP-1) agonists.
- These medications, which include semaglutide, tirzepatide, and liraglutide, are increasingly used to treat type 2 diabetes, obesity, and other metabolic conditions.
GLP-1 Agonist Virtual Registry
This research-ready dataset, known as a
Read More
Vantive Launches as Independent Vital Organ Therapy Company
What You Should Know:
- Vantive, formerly known as Baxter Kidney Care, today announced its launch as a new standalone company focused on vital organ therapies.
- The formation follows the completion of its acquisition by funds managed by Carlyle (NASDAQ: CG) from Baxter International Inc. (NYSE: BAX). Building on a 70-year legacy of innovation in kidney care, Vantive is committed to extending lives and expanding possibilities for patients with kidney disease and other vital
Read More
Cellular Connectivity: The Future of Home Medical Devices
The global home medical equipment market is experiencing explosive growth. Smart devices are being used to monitor and treat patients suffering from diabetes, cardiac disorders, and other medical conditions without exposing those patients to the risk of hospital-acquired infections. Numerous organizations, including the World Health Organization and the National Council of Aging, are promoting self-health management to give patients better outcomes.
This trend leverages digital technology to
Read More
Medidata and Cognizant Expand Partnership to Accelerate Clinical Trial Development
What You Should Know:
- Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata's life sciences clients and expand the strategic alliance partnership.
- Over the years, the companies have partnered to deliver a comprehensive framework supporting life sciences clients, emphasizing customer success, patient service desk, implementation,
Read More
Owkin Doses First Patient in Phase I Trial of AI-Optimized Cancer Therapy OKN4395
What You Should Know:
- Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function in patients with advanced solid tumors.
- OKN4395 represents a novel approach to cancer treatment by targeting multiple immunosuppressive pathways simultaneously.
OKN4395 Background
OKN4395 is a first-in-class asset that selectively inhibits three
Read More
